Stay updated on Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.

Latest updates to the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page
- Check4 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page transitioned from a 403 error to displaying the ClinicalTrials.gov study record for NCT03945773, restoring access to the study details and navigation.SummaryDifference0.5%

- Check25 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating restricted access to the study record rather than listing study details or results.SummaryDifference18%

- Check46 days agoChange DetectedA new revision tag 'Revision: v3.6.6' was added and the previous 'Revision: v3.6.5' tag was removed. This indicates an update to the page's version.SummaryDifference0.0%

- Check53 days agoChange Detected2018 ( U.S. NIH Grant/Contract ) was added to the study's identifiers, signaling NIH funding attribution. This addition adds funding-related metadata to the record without changing the study's design or reported results.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page's revision label changed from v3.6.4 to v3.6.5, signaling a small update to the Study Details page.SummaryDifference0.0%

Stay in the know with updates to Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.